A modelling study suggests that the lenacapavir anti-HIV jab could potentially end Aids in South Africa by 2032 if between two and four million HIV-negative individuals use it annually over the next eight years. The key question raised is how much should be paid for the jab to make this ambitious goal a reality, highlighting the importance of affordability and accessibility in combating the HIV epidemic in the country.
Full Article
French row with Algeria escalates further with tit-for-tat expulsions
Paul KirbyEurope digital editorFrance has recalled its ambassador to Algeria and expelled 12 Algerian diplomats amid escalating diplomatic tensions following the arrest of an Algerian consular official linked to the kidnapping of a government critic. Relations between the countries have been deteriorating since Macron's support for Moroccan sovereignty over Western Sahara, with both nations blaming each other for the crisis. Despite attempts to ease tensions, including discussions between Macron and Algeria's president, the situation continues...
Read more